Moving beyond race-based drugs
Prescribing certain medications on the basis of a patient’s race has long come under fire from those uneasy with using race as a surrogate for biology when treating disease. But there are multiple challenges to overcome before we can move beyond race-based treatment decisions, writes Duke University geneticist and bioethicist Charmaine Royal in a perspective piece published May 25 in the New England Journal of Medicine. In […]